Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2008-01-17

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm070759mPMID 18198821
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Scalaradial, a Dialdehyde‐Containing Marine Metabolite That Causes an Unexpected Noncovalent PLA2 Inactivation

  2007cited by this paper
• Ligand docking and structure-based virtual screening in drug discovery.

  2007cited by this paper
• 6-Acylamino-2-amino-4-methylquinolines as potent melanin-concentrating hormone 1 receptor antagonists: structure-activity exploration of eastern and western parts.

  2006cited by this paper
• Structure-based development of target-specific compound libraries.

  2006cited by this paper
• Obésité : où en sommes-nous?

  2006cited by this paper
• 6-(4-chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonist.

  2006cited by this paper
• The discovery and optimization of pyrimidinone-containing MCH R1 antagonists.

  2006cited by this paper
• [Obesity: where are we now?].

  2006cited by this paper
• Recombinant G protein-coupled receptors from expression to renaturation: a challenge towards structure

  2006cited by this paper
• Discovery of orally efficacious melanin-concentrating hormone receptor-1 antagonists as antiobesity agents. Synthesis, SAR, and biological evaluation of bicyclo[3.1.0]hexyl ureas.

  2006cited by this paper
• Childhood Obesity: Trends and Potential Causes

  2006cited by this paper
• Melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity.

  2006cited by this paper
• Comparative modeling for protein structure prediction.

  2006cited by this paper
• Structure of the rhodopsin dimer: a working model for G-protein-coupled receptors.

  2006cited by this paper
• Advances in homology protein structure modeling.

  2006cited by this paper
• Bicyclic[4.1.0]heptanes as phenyl replacements for melanin concentrating hormone receptor antagonists.

  2006cited by this paper
• Sequence comparison and protein structure prediction.

  2006cited by this paper
• Biaryl ureas as potent and orally efficacious melanin concentrating hormone receptor 1 antagonists for the treatment of obesity.

  2005cited by this paper
• Discovery of bicycloalkyl urea melanin concentrating hormone receptor antagonists: orally efficacious antiobesity therapeutics.

  2005cited by this paper
• The Challenge of Considering Receptor Flexibility in Ligand Docking and Virtual Screening

  2005cited by this paper
• 6-Acylamino-2-aminoquinolines as potent melanin-concentrating hormone 1 receptor antagonists. Identification, structure-activity relationship, and investigation of binding mode.

  2005cited by this paper
• Discovery and characterization of aminopiperidinecoumarin melanin concentrating hormone receptor 1 antagonists.

  2005cited by this paper
• Identification of 2-(4-benzyloxyphenyl)-N- [1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesity.

  2005cited by this paper
• Conformational Sampling of Protein Flexibility in Generalized Coordinates: Application to Ligand Docking

  2005cited by this paper
• Representing receptor flexibility in ligand docking through relevant normal modes.

  2005cited by this paper
• Recombinant G protein-coupled receptors from expression to renaturation: a challenge towards structure

  2005cited by this paper
• A virtual screening approach to finding novel and potent antagonists at the melanin-concentrating hormone 1 receptor.

  2004cited by this paper
• Virtual Screening Using Protein-Ligand Docking: Avoiding Artificial Enrichment

  2004cited by this paper
• Ligand-supported homology modeling of g-protein-coupled receptor sites: models sufficient for successful virtual screening.

  2004cited by this paper
• Structural features of the inactive and active states of the melanin‐concentrating hormone receptors: Insights from molecular simulations

  2004cited by this paper
• The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure.

  2004cited by this paper
• Determinants of retinoid X receptor transcriptional antagonism.

  2004cited by this paper
• Protein flexibility in ligand docking and virtual screening to protein kinases.

  2004cited by this paper
• A novel modeling protocol for protein receptors guided by bound-ligand conformation.

  2003cited by this paper
• Structure of bovine rhodopsin in a trigonal crystal form.

  2003cited by this paper
• Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin.

  2003cited by this paper
• Ligand-supported homology modelling of protein binding-sites using knowledge-based potentials.

  2003cited by this paper
• Structure‐based identification of binding sites, native ligands and potential inhibitors for G‐protein coupled receptors

  2003cited by this paper
• Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography

  2002cited by this paper
• Melanin-concentrating hormone and its receptors: state of the art.

  2002cited by this paper
• T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist.

  2002cited by this paper
• Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor

  2002cited by this paper
• Mutation of a single TMVI residue, Phe(282), in the beta(2)-adrenergic receptor results in structurally distinct activated receptor conformations.

  2002cited by this paper
• Molecular Cloning and Functional Characterization of MCH2, a Novel Human MCH Receptor*

  2001cited by this paper
• Cloning of a novel G protein-coupled receptor, SLT, a subtype of the melanin-concentrating hormone receptor.

  2001cited by this paper
• SLC-1 receptor mediates effect of melanin-concentrating hormone on feeding behavior in rat: a structure-activity study.

  2001cited by this paper
• Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R

  2001cited by this paper
• Selective melanin-concentrating hormone -1 (MCH1) receptor antagonists and use thereof

  2001cited by this paper
• Melanin-concentrating hormone receptor: an orphan receptor fits the key.

  2000cited by this paper
• Knowledge-based scoring function to predict protein-ligand interactions.

  2000cited by this paper
• Molecular characterization of the melanin-concentrating hormone/receptor complex: identification of critical residues involved in binding and activation.

  2000cited by this paper
• Crystal structure of rhodopsin: A G protein-coupled receptor.

  2000cited by this paper
• Phe310 in Transmembrane VI of the α1B-Adrenergic Receptor Is a Key Switch Residue Involved in Activation and Catecholamine Ring Aromatic Bonding*

  1999cited by this paper
• Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1

  1999cited by this paper
• Molecular characterization of the melanin-concentrating-hormone receptor

  1999cited by this paper
• Docking small ligands in flexible binding sites

  1998cited by this paper
• Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus.

  1998cited by this paper
• Mice lacking melanin-concentrating hormone are hypophagic and lean

  1998cited by this paper
• A role for melanin-concentrating hormone in the central regulation of feeding behaviour

  1996cited by this paper
• Melanotropic peptides in the mammalian brain: the melanin-concentrating hormone.

  1996cited by this paper
• ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation

  1994cited by this paper
• Energy parameters in polypeptides. 10. Improved geometrical parameters and nonbonded interactions for use in the ECEPP/3 algorithm, with application to proline-containing peptides

  1994cited by this paper
• Comparative protein modelling by satisfaction of spatial restraints.

  1993cited by this paper
• Monte Carlo-minimization approach to the multiple-minima problem in protein folding.

  1987cited by this paper
• Characterization of melanin-concentrating hormone in chum salmon pituitaries

  1983cited by this paper

• Convergence of Computer-Aided Drug Discovery and Artificial Intelligence: Towards Next-Generation Therapeutics

  2025cites this paper
• Homology modeling, binding site identification, molecular docking and molecular dynamics simulation study of emerging and promising drug target of Wnt signaling – Human Porcupine enzyme

  2024cites this paper
• Molecular determinants of antagonist interactions with chemokine receptors CCR2 and CCR5

  2023cites this paper
• Computational Chemistry for the Identification of Lead Compounds for Radiotracer Development

  2023influential citation
• Hic Sunt Dracones: Molecular Docking in Uncharted Territories with Structures from AlphaFold2 and RoseTTAfold

  2023cites this paper
• How good are AlphaFold models for docking-based virtual screening?

  2022cites this paper
• Pharmaceutical interest of in-silico approaches

  2022cites this paper
• AlignMe: an update of the web server for alignment of membrane protein sequences

  2022cites this paper
• A closer look at N2,6-substituted 1,3,5-triazine-2,4-diamines: Advances in synthesis and biological activities.

  2022cites this paper
• Structure-based virtual screening and molecular dynamics of potential inhibitors targeting sodium-bile acid co-transporter of carcinogenic liver fluke Clonorchis sinensis

  2022cites this paper
• Molecular modeling study of the testosterone metabolizing enzyme UDP-glucuronosyltransferase 2B17.

  2021cites this paper
• LSU Digital Commons LSU Digital Commons Status of GPCR modeling and docking as reflected by community- Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment wide GPCR Dock 2010 assessment

  2021cites this paper
• A practical guide to large-scale docking

  2021cites this paper
• Computational Prediction of Chemical Tools for Identification and Validation of Synthetic Lethal Interaction Networks.

  2021cites this paper
• Discovery and Validation of Lmj_04_BRCT Domain, a Novel Therapeutic Target: Identification of Candidate Drugs for Leishmaniasis

  2021cites this paper
• A unique ligand‐steered strategy for CC chemokine receptor 2 homology modeling to facilitate structure‐based virtual screening

  2021cites this paper
• Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins

  2020cites this paper
• Structure-based discovery of potential inhibitors targeting sodium-bile acid co-transporter of carcinogenic liver uke Clonorchis sinensis

  2020cites this paper
• Structure-based discovery of potential inhibitors targeting sodium-bile acid co-transporter of carcinogenic liver fluke Clonorchis sinensis

  2020cites this paper
• Structural Genomics and Interactomics of 2019 Wuhan Novel Coronavirus, SARS-CoV-2, Indicate Evolutionary Conserved Functional Regions of Viral Proteins

  2020cites this paper
• In silico Drug Repurposing for COVID-19: Targeting SARS-CoV-2 Proteins through Docking and Quantum Mechanical Scoring

  2020cites this paper
• Efficiency of Homology Modeling assisted Molecular Docking in G-protein coupled receptors.

  2020cites this paper
• Functional and druggability analysis of the SARS-CoV-2 proteome

  2020cites this paper
• Homology Modeling

  2020cites this paper
• In silico Drug Repurposing for COVID‐19: Targeting SARS‐CoV‐2 Proteins through Docking and Consensus Ranking

  2020cites this paper
• Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19)

  2020cites this paper
• Identification and experimental confirmation of novel cGMP efflux inhibitors by virtual ligand screening of vardenafil-analogues.

  2020cites this paper
• Structural genomics and interactomics of 2019 Wuhan novel coronavirus, 2019-nCoV, indicate evolutionary conserved functional regions of viral proteins

  2020cites this paper
• Algorithms for Structure Comparison and Analysis: Homology Modelling of Proteins

  2019cites this paper
• Methods for Virtual Screening of GPCR Targets: Approaches and Challenges.

  2018cites this paper
• A fluorescence nanoscopy marker for corticotropin-releasing hormone type 1 receptor: computer design, synthesis, signaling effects, super-resolved fluorescence imaging, and in situ affinity constant in cells.

  2018cites this paper
• Computational chemistry in drug lead discovery and design

  2018cites this paper
• Allosteric modulation of GABAergic and glutamatergic metabotropic receptors

  2018cites this paper
• Recent Trends and Applications of Molecular Modeling in GPCR–Ligand Recognition and Structure-Based Drug Design

  2018cites this paper
• Molecular Modeling of Drug–Transporter Interactions—An International Transporter Consortium Perspective

  2018cites this paper
• Salvianolic acids from antithrombotic Traditional Chinese Medicine Danshen are antagonists of human P2Y1 and P2Y12 receptors

  2018cites this paper
• Palladium-catalyzed site-selective hydrogen isotope exchange (HIE) reaction of arylsulfonamides using amino acid auxiliary

  2018cites this paper
• Structure‐based drug design for envelope protein E2 uncovers a new class of bovine viral diarrhea inhibitors that block virus entry

  2018cites this paper
• Computational Methods for GPCR Drug Discovery

  2018cites this paper
• Identification of a Novel Class of BRD4 Inhibitors by Computational Screening and Binding Simulations

  2017cites this paper
• Ligand-guided homology modelling of the GABAB2 subunit of the GABAB receptor

  2017cites this paper
• Modeling and Design for Membrane Protein Targets

  2017cites this paper
• The GPR139 reference agonists 1a and 7c, and tryptophan and phenylalanine share a common binding site

  2017cites this paper
• The BigLEN-GPR171 Peptide Receptor System Within the Basolateral Amygdala Regulates Anxiety-Like Behavior and Contextual Fear Conditioning

  2017cites this paper
• Discovery of novel dengue virus entry inhibitors via a structure-based approach.

  2017cites this paper
• Function and structure-based screening of compounds, peptides and proteins to identify drug candidates.

  2017cites this paper
• Investigating molecular dynamics-guided lead optimization of EGFR inhibitors.

  2016cites this paper
• Biased signaling: potential agonist and antagonist of PAR2

  2016cites this paper
• Identification of Novel Smoothened Ligands Using Structure-Based Docking

  2016cites this paper
• Discovery of new selective antagonists of G-protein coupled receptors of therapeutic interest

  2016cites this paper
• Galaxy7TM: flexible GPCR–ligand docking by structure refinement

  2016cites this paper
• Discovery of Mycobacterium tuberculosis InhA Inhibitors by Binding Sites Comparison and Ligands Prediction.

  2016cites this paper
• Structure-Based Rational Design of Adenosine Receptor Ligands.

  2016cites this paper
• Homology modeling: an important tool for the drug discovery

  2015cites this paper
• - Library Design, Chemical Space, and Drug Likeness

  2015cites this paper
• Computational studies of biomolecular screening and interactions

  2015cites this paper
• Protein Structure Modeling in Drug Design

  2015cites this paper
• VU Research Portal In silico Medicinal

  2015cites this paper
• Advancements in therapeutically targeting orphan GPCRs

  2015cites this paper
• Identifying modulators of CXC receptors 3 and 4 with tailored selectivity using multi-target docking.

  2015cites this paper
• Identification of Substituted Naphthotriazolediones as Novel Tryptophan 2,3-Dioxygenase (TDO) Inhibitors through Structure-Based Virtual Screening.

  2015cites this paper
• Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models.

  2015cites this paper
• G-Protein Coupled Receptors (GPCRs): A Comprehensive Computational Perspective.

  2015cites this paper
• Sanna Niinivehmas Computational Studies of Biomolecular Screening and Interactions

  2015cites this paper
• Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65

  2015cites this paper
• Discovery by virtual screening of ethionamide boosters for tuberculosis treatment

  2015cites this paper
• Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein‐coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example

  2015cites this paper
• Toward Complete Cellular Pocketomes and Predictive Polypharmacology

  2015cites this paper
• - Protein–Ligand Docking: From Basic Principles to Advanced Applications

  2015cites this paper
• Supercomputers in Modeling of Biological Systems

  2015cites this paper
• Open challenges in structure-based virtual screening: Receptor modeling, target flexibility consideration and active site water molecules description.

  2015cites this paper
• Computational Approaches in the Structure–Function Studies of Dopamine Receptors

  2015cites this paper
• Regioselective ortho olefination of aryl sulfonamide via rhodium-catalyzed direct C-H bond activation.

  2014cites this paper
• Structure-based discovery of selective serotonin 5-HT(1B) receptor ligands.

  2014cites this paper
• Methods for docking small molecules to macromolecules: a user's perspective. 2. Applications.

  2014cites this paper
• Characterizing the Structure, Function, and Evolution of Human Solute Carrier (SLC) Transporters Using Computational Approaches

  2014influential citation
• Modelling three-dimensional protein structures for applications in drug design.

  2014cites this paper
• Profiling the Interaction Mechanism of Quinoline/Quinazoline Derivatives as MCHR1 Antagonists: An in Silico Method

  2014cites this paper
• From three-dimensional GPCR structure to rational ligand discovery.

  2014cites this paper
• Structure and putative signaling mechanism of Protease activated receptor 2 (PAR2) - a promising target for breast cancer.

  2014cites this paper
• Strategies for Improved Modeling of GPCR-Drug Complexes: Blind Predictions of Serotonin Receptors Bound to Ergotamine

  2014cites this paper
• The GPCR crystallography boom: providing an invaluable source of structural information and expanding the scope of homology modeling.

  2014cites this paper
• From Receptors to Ligands: Fragment-assisted Drug Design for GPCRsApplied to the Discovery of H3 and H4 Receptor Antagonists

  2013cites this paper
• Pharmaceutical and industrial protein engineering: where we are?

  2013cites this paper
• Optimized method of G-protein-coupled receptor homology modeling: its application to the discovery of novel CXCR7 ligands.

  2013cites this paper
• Ligand Pose and Orientational Sampling in Molecular Docking

  2013cites this paper
• Computational approaches for ligand discovery and design in class-A G protein- coupled receptors.

  2013cites this paper
• Ligand-Optimized Homology Models of D1 and D2 Dopamine Receptors: Application for Virtual Screening

  2013cites this paper
• Mastering tricyclic ring systems for desirable functional cannabinoid activity.

  2013cites this paper
• Fighting Obesity with a Sugar-Based Library: Discovery of Novel MCH-1R Antagonists by a New Computational-VAST Approach for Exploration of GPCR Binding Sites

  2013cites this paper
• Development of 7TM receptor-ligand complex models using ligand-biased, semi-empirical helix-bundle repacking in torsion space: application to the agonist interaction of the human dopamine D2 receptor

  2013cites this paper
• Dérivés sulfoxydes amido-benzyliques

  2013cites this paper
• Recent trends and future prospects in computational GPCR drug discovery: from virtual screening to polypharmacology.

  2013cites this paper
• Molecular docking methodologies.

  2013cites this paper
• From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.

  2013cites this paper
• Isoform Selectivity of Adenylyl Cyclase Inhibitors: Characterization of Known and Novel Compounds

  2013cites this paper
• Molecular modeling and ligand docking for solute carrier (SLC) transporters.

  2013cites this paper
• Structure prediction and molecular dynamics simulations of a G-protein coupled receptor: human CCR2 receptor

  2013cites this paper
• Docking and scoring with ICM: the benchmarking results and strategies for improvement

  2012cites this paper
• Novel cGMP efflux inhibitors identified by virtual ligand screening (VLS) and confirmed by experimental studies.

  2012cites this paper